Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer

被引：3
作者：
Moretto, Roberto [1 ,2 ]
Falcone, Alfredo [1 ,2 ]
Cremolini, Chiara [1 ,2 ]
机构：
[1] Univ Pisana, Azienda Osped, Unit Med Oncol 2, Pisa, Italy
[2] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
来源：
INTERNATIONAL JOURNAL OF CANCER | 2020年 / 146卷 / 09期
关键词：
CAPECITABINE;
D O I：
10.1002/ijc.32884
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2652 / 2654
页数：3
相关论文
共 8 条
[1]  
[Anonymous], 2019, EUPDATE EARL COL CAN
[2]   Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer [J].
Cassidy, Jim ;
Clarke, Stephen ;
Diaz-Rubio, Eduardo ;
Scheithauer, Werner ;
Figer, Arie ;
Wong, Ralph ;
Koski, Sheryl ;
Lichinitser, Mikhail ;
Yang, Tsai-Shen ;
Rivera, Fernando ;
Couture, Felix ;
Sirzen, Florin ;
Saltz, Leonard .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :2006-2012
[3]   Duration of Adjuvant Chemotherapy for Stage III Colon Cancer [J].
Grothey, A. ;
Sobrero, A. F. ;
Shields, A. F. ;
Yoshino, T. ;
Paul, J. ;
Taieb, J. ;
Souglakos, J. ;
Shi, Q. ;
Kerr, R. ;
Labianca, R. ;
Meyerhardt, J. A. ;
Vernerey, D. ;
Yamanaka, T. ;
Boukovinas, I. ;
Meyers, J. P. ;
Renfro, L. A. ;
Niedzwiecki, D. ;
Watanabe, T. ;
Torri, V. ;
Saunders, M. ;
Sargent, D. J. ;
Andre, T. ;
Iveson, T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) :1177-1188
[4]   Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC). [J].
Iveson, Timothy ;
Sobrero, Alberto F. ;
Yoshino, Takayuki ;
Sougklakos, Ioannis ;
Ou, Fang-Shu ;
Meyers, Jeffery P. ;
Shi, Qian ;
Saunders, Mark P. ;
Labianca, Roberto ;
Yamanaka, Takeharu ;
Boukovinas, Ioannis ;
Hollander, Niels Henrik ;
Torri, Valter ;
Yamazaki, Kentaro ;
Georgoulias, Vassilis ;
Lonardi, Sara ;
Harkin, Andrea ;
Rosati, Gerardo ;
Paul, James .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[5]   Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline [J].
Lieu, Christopher ;
Kennedy, Erin B. ;
Bergsland, Emily ;
Berlin, Jordan ;
George, Thomas J. ;
Gill, Sharlene ;
Gold, Philip J. ;
Hantel, Alex ;
Jones, Lee ;
Mahmoud, Najjia ;
Meyerhardt, Jeffrey ;
Morris, Arden M. ;
Ruiz-Garcia, Erika ;
You, Y. Nancy ;
Baxter, Nancy .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (16) :1436-+
[6]  
NCCN Guidelines, 2019, COL CANC VERS 3 2019
[7]   Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals [J].
Rehal, Sunita ;
Morris, Tim P. ;
Fielding, Katherine ;
Carpenter, James R. ;
Phillips, Patrick P. J. .
BMJ OPEN, 2016, 6 (10)
[8]   Capecitabine as adjuvant treatment for stage III colon cancer [J].
Twelves, C ;
Wong, A ;
Nowacki, MP ;
Abt, M ;
Burris, H ;
Carrato, A ;
Cassidy, J ;
Cervantes, A ;
Fagerberg, J ;
Georgoulias, V ;
Husseini, F ;
Jodrell, D ;
Koralewski, P ;
Kröning, H ;
Maroun, J ;
Marschner, N ;
McKendrick, J ;
Pawlicki, M ;
Rosso, R ;
Schüller, J ;
Seitz, JF ;
Stabuc, B ;
Tujakowski, J ;
Van Hazel, G ;
Zaluski, J ;
Scheithauer, W .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2696-2704
1